- GlobeNewswire•15 days agoOrganovo and Collaborators Publish Data in Toxicological Sciences Demonstrating Power of 3D Bioprinted Human Liver Tissues in Modeling Drug-Induced Liver Injury Leading to Fibrosis
SAN DIEGO, Sept. 13, 2016-- Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3 D bioprinting technology, today announced ...
- GlobeNewswire•15 days ago
SEATTLE, Sept. 13, 2016-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Kirk Malloy, Ph.D. ...
Organovo Holdings, Inc. (ONVO)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||3.50 x 500|
|Day's Range||3.85 - 3.95|
|52wk Range||1.60 - 4.99|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-9.26|
|Avg Vol (3m)||1,104,785|
|Dividend & Yield||N/A (N/A)|